Hikal Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Hikal Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
HIKAL LTD.

Click to see a quick summary and important updates about this stock!Dismiss

Hikal Ltd.

BSE: 524735, NSE: HIKAL

  • Market Capitalisation info

    ₹4,708 Cr


  • 12 Month Earnings info

    ₹82 Cr

  • Price to Earnings info

    58.03

₹382.65

As on 09-Dec-2022 IST

up-down-arrow-10.95-2.78%

  • Prev Close info

    393.60

  • Day's Openinfo

    394.45

  • Today's Highinfo

    395.90

  • Today's Lowinfo

    372.75

  • Today's Volumeinfo

    10,08,900

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Hikal
-27.36 11.15 12.40 -25.41 52.21 19.54 20.02
S&P BSE Healthcare
-10.79 -2.67 1.25 -6.69 20.54 10.76 11.36
S&P BSE Small Cap
0.34 0.91 0.28 2.69 30.37 10.17 14.78
As on 09-Dec-2022
2021
2020
2019
2018
2017
2016
2015
Hikal
215.61 41.45 -26.92 -1.08 9.44 27.16 10.09
S&P BSE Small Cap
62.77 32.11 -6.85 -23.41 59.64 1.77 6.76
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        No Review & Analysis are available.

        Other Details

        Incorporated

        1988

        Chairman

        Jai Hiremath

        Managing Director

        Sameer Hiremath

        Group

        Kalyani

        Headquarters

        Mumbai, Maharashtra
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹4,708.24 Cr

        • Revenue (TTM) info

          ₹1,954.42 Cr

        • Earnings (TTM) info

          ₹81.89 Cr

        • Cash info

          ₹50.67 Cr

        • Total Debt info

          ₹674.44 Cr

        • Promoters' ownership info

          68.77%

        • Liquidity info

          High

        • 52 Week range info

          ₹212.00 - 595.00

        • Face value info

          ₹2.00

        • Shares outstanding info

          12,33,00,750

        • 10 Years Aggregate:

          CFO: ₹1,798.81 Cr

          EBITDA: ₹2,409.45 Cr

          Net Profit: ₹796.84 Cr

        About The Company

        • Business

          Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

        • Incorporated

          1988

        • Chairman

          Jai Hiremath

        • Managing Director

          Sameer Hiremath

        • Group

          Kalyani

        • Listing info

          BSE: 524735, NSE: HIKAL

        • Country

          India

        • Headquarters info

          Mumbai, Maharashtra

        • Website info

          www.hikal.com